Instructions for Mirvaso Derm (brimonidine) gel
English Product Name
Mirvaso Derm
Release Form
Gel for external use
Description Mirvaso Derm
Gel for external use 0.5% white to light yellow, opaque.
1 g
brimonidine tartrate 5 mg
Auxiliary substances: carbomer - 12.5 mg, methylparahydroxybenzoate - 1 mg, phenoxyethanol - 4 mg, glycerol - 55 mg, titanium dioxide - 0.625 mg, propylene glycol - 55 mg, sodium hydroxide - up to pH 6.0, purified water - up to 1000 mg.
10 g - plastic laminated tubes (1) - cardboard packs.
30 g - plastic laminated tubes (1) - cardboard packs.
ATX codes
D11AX21 Brimonidine
Clinical and pharmacological groups / Group affiliation
Selective alpha<SUB>2</SUB>-agonist for rosacea
Active ingredient
brimonidine tartrate
Pharmacotherapeutic group: Mirvaso Derm
the inventive agent for treating facial erythema in rosacea is a selective alpha2-adrenomimetic.
Pharmacological effect:
said agent is intended for external use and is a highly selective agonist of α2-adrenergic receptors. Its affinity for α2-adrenergic receptors is 1000 times that of α1-adrenergic receptors. Applying a highly selective α2-adrenergic agonist to the facial skin reduces erythema by direct vasoconstriction of the small blood vessels of the dermis.
Pharmacotherapeutic group Mirvaso Derm:
the inventive agent for treating facial erythema in rosacea is a selective alpha2-adrenomimetic.
Pharmacological effect Mirvaso Derm:
said agent is intended for external use and is a highly selective agonist of α2-adrenergic receptors. Its affinity for α2-adrenergic receptors is 1000 times that of α1-adrenergic receptors. Applying a highly selective α2-adrenergic agonist to the facial skin reduces erythema by direct vasoconstriction of the small blood vessels of the dermis.
Indications Mirvaso Derm
it is recommended for the treatment of facial erythema in rosacea.
Method of application, course and dosage:
this product is intended for external use only. Apply a thin layer on the skin of each of the 5 facial areas (forehead, chin, nose, cheeks) once a day if erythema is present. The maximum recommended daily dose is 1 g (roughly equal to 5 match heads).